Retrophin, Inc. logo

RTRX

Retrophin, Inc. · NASDAQ

Retrophin, Inc. (RTRX) is a Major Pharmaceuticals company listed on NASDAQ. There were no new wire items for RTRX in the last 30 days. The most recent was published Nov 16, 2020.

Latest news

6 items

RTRX FAQ

6 questions
  • What is the latest news on RTRX?
    Quantisnow has not tracked any new filings, ratings or press releases for RTRX in the last 30 days. The most recent wire item was published on November 16, 2020.
  • Where does RTRX stock trade?
    Retrophin, Inc. (RTRX) is listed on NASDAQ.
  • What sector and industry is RTRX in?
    Retrophin, Inc. operates in the Health Care sector, Major Pharmaceuticals industry.
  • When did Retrophin, Inc. go public?
    Retrophin, Inc. (RTRX) completed its IPO in n/a.
  • What companies are similar to RTRX?
    Notable peers in the same industry include ADMS (Adamas Pharmaceuticals, Inc.), ADRO (Aduro Biotech, Inc.), ADXS (Advaxis, Inc.), ARPO (Aerpio Pharmaceuticals, Inc.), AIMT (Aimmune Therapeutics, Inc.). Compare RTRX side-by-side with any of them on Quantisnow.
  • How can I track RTRX on Quantisnow?
    Quantisnow aggregates Retrophin, Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow RTRX to receive live email and push alerts on every new disclosure.